Mateusz Kaczmarek, Author at TechStock²

Rigetti Stock’s Quantum Roller Coaster: 3,000% Surge, Government Backing & Big Risks

Recent Stock Performance & News Drivers Rigetti’s stock has been on a wild roller coaster in recent months, reflecting both speculative hype and substantive news. Starting in early September, RGTI shares went on a tear – nearly quadrupling in value

3 November 2025

SoFi Stock Soars to New Highs After Record Earnings – Why Some Say It’s Just the Beginning

SoFi Stock Skyrockets on Earnings Beat SoFi’s stock has been on an explosive upward trajectory in 2025, recently soaring to all-time highs following its third-quarter earnings report. The share price jumped about 20% in the days around the Q3 release,

3 November 2025

Earnings Reports · Financial News · Growth Stocks · Investing · NASDAQ:SOFI · Stock Market

Bitfarms (BITF) Skyrockets on AI Pivot – Bitcoin Miner’s 400% Rally and Future Outlook

Recent News & Developments (Late October – November 2025) Stock Price and Market Performance Bitfarms’ stock has experienced an explosive rally in 2025. After starting the year near penny-stock levels, BITF climbed from under $1 in Q1 to over $6

3 November 2025

Artificial Intelligence · Bitcoin Mining · Cryptocurrency · Investment Strategies · NASDAQ:BITF · Stock Market

Plug Power’s High-Stakes Hydrogen Comeback: Stock Surge, CEO Shakeup & Big Deals Fuel 2025 Hopes

Stock Surge from Penny Levels – But Volatility Remains Plug Power’s stock has been on a wild ride in 2025. After collapsing to penny-stock territory (briefly around $0.70–$0.80 in spring investing.com), PLUG staged a dramatic rally over the summer –

3 November 2025

Business Deals · Clean Technology · Hydrogen Energy · Leadership Changes · NASDAQ:PLUG · Stock Market

5 Dividend ETFs That Could Pay You for Life – One Could Turn $500/Month Into $680,000

Why Dividend ETFs for Lifetime Income? Dividend-focused ETFs have become go-to tools for investors seeking steady retirement income. By buying a single ETF, you get exposure to a basket of companies that regularly distribute profits to shareholders as dividends. This

3 November 2025

Dividend Investing · ETFs · NYSE:JEPI · NYSE:SCHD · NYSE:VYM · Passive Income · Personal Finance · Wealth Building

Record 2026 Tax Refund Surge Looms as New Tax Cuts Fuel a $50 Billion “Stimulus”

A Tax Refund Windfall on the Horizon American taxpayers are poised for a record tax refund season in early 2026, with millions set to get substantially larger refunds when they file their 2025 income-tax returns. The reason is an unusual

3 November 2025

Economic Stimulus · Government Finance · Personal Finance · Tax Policy · Tax Refunds

Delisted Xbox 360 Games Suddenly Reappear – Backward Compatibility on the Horizon?

Delisted Xbox 360 Games Reappear on Microsoft Store A wave of nostalgia hit Xbox fans when multiple Xbox 360 titles that had been delisted suddenly reappeared on the Microsoft Store in late October/early November 2025. These games, previously removed from

3 November 2025

Backward Compatibility · Game Industry · Gaming News · NASDAQ:MSFT · Video Games · Xbox

AI Chip Frenzy Sends Lam Research Soaring 117% – More Upside Ahead?

Lam Research Rides the AI Wave to New Highs Lam Research, a leading maker of semiconductor fabrication equipment, has been one of 2025’s standout stocks. The company’s share price has more than doubled this year, up about 117% as of

3 November 2025

AI · Investing · NASDAQ:LRCX · Semiconductors · Stock Market · Technology

Axsome Therapeutics (AXSM) Skyrockets on CNS Breakthroughs: Stock Surge, Pipeline Wins, and 2025 Outlook

Stock Performance and Recent Trend Axsome’s stock has been a standout performer in 2025. As of November 3, 2025, AXSM trades around $134–$135 per share, roughly doubling from its 52-week low of $75.56 finviz.com. The stock has gained about 60%

3 November 2025

Biotech Stocks · CNS Disorders · Drug Pipeline · Investment Insights · Market Analysis · NASDAQ:AXSM

ClearPoint Neuro (CLPT) Stock Skyrockets on Brain Therapy Breakthroughs – 2025 Deep Dive

Stock Performance & Trading Trends (2025) ClearPoint Neuro’s stock has delivered dramatic gains in 2025, transforming from a little-known small-cap into a high-flyer. The share price rallied over 300% from 2024 lows, driven by positive news in both the company’s

3 November 2025

Health Innovation · Investment Insights · Medical Technology · Neuroscience · Stock Market

Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Analyst outlook & forecast: Long-term, analysts model robust growth. For example, one financial model projects ~18% revenue CAGR: ~$3.3 billion in sales by 2028 and ~$261 million net income simplywall.st. Another estimate sees revenue rising from ~$2.35 B in 2025 to ~$3.34 B by

3 November 2025

Expert Opinions · Healthcare Innovation · NYSE:HIMS · Stock Market · Weight Loss · Wellness Trends

CURE Pharmaceutical (CURR) Stock Skyrockets Amid Wellness Pivot – What’s Next for Investors?

High-Flying Share Price and Recent Performance 🚀 As of November 3, 2025, CURE Pharmaceutical’s stock is trading around $3.6 per share, reflecting an explosive rise in late October. On Friday, Oct 31, the stock closed at $3.78, up from $2.89

3 November 2025

Investing · Market Analysis · Pharmaceutical Industry · Stocks · Wellness